Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth

Q: How often is Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan portfolio data updated?

Portfolio holdings for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan are updated monthly. SEBI mandates all AMCs to disclose their complete portfolio within 10 days of each month end. RightAdvise sources this data directly from official AMFI portfolio disclosures.

Equity Data as of May 2026 Comparing Apr 2026 → May 2026

Share: WhatsApp X

Stocks Held

May 2026

Equity Holdings

₹125.78 Cr

Equity only, excl. debt & cash

Top 5 Weight

32.7%

Moderate

Top 10 Weight

50.8%

Moderate

Changes

0 new · 0 exits

Top Sector

Pharmaceuticals & Biotechnology

54.2% of portfolio

📋 What Happened This Month Among existing holdings, Laurus Labs Limited saw the biggest increase — now at 3.16% of the portfolio. Sun Pharmaceutical Industries Limited was trimmed the most, now at 11.42%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 54.2%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.

How Has the NAV Performed?

1 year history · Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth

+2.56%

+9.72%

+7.75%

+17.36%

Latest NAV

₹23.20

24 Jun 2026

52W High

₹23.20

At High

52W Low

₹18.34

+26% from Low

Calendar Year Returns

Jan 1 to Dec 31 each year. Simple point-to-point — not CAGR.

2025

+5.5%

2024

+29.6%

2023

+25.1%

2022

-4.8%

2021

+18.8%

Rolling Returns

Performance across every possible investment start date.

1Y Rolling Avg

15.5%

+ve in 79% windows

50.9% / -10.6%

3Y Rolling Avg

18.0% p.a.

+ve in 100% windows

25.4% / 13.4%

5Y Rolling Avg

15.0% p.a.

+ve in 100% windows

17.0% / 13.5%

Crisis Period Behaviour

"Pre-inception" = fund didn't exist during that period.

2024–25 Tariff

-12.2%

Rec: Oct 2025 (9 mo)

COVID-19 Crash

Pre-inception

Rec: N/A

2022 Rate Hike

-14.3%

Rec: Jun 2023 (1yr 5mo)

2018 IL&FS

Pre-inception

Rec: N/A

Risk Ratios

3 years daily NAV · Risk-free rate 6.5% p.a. What do these mean? →

Sharpe Ratio (3Y)

1.35

Return per unit of risk. >1 is good.

Sortino Ratio (3Y)

1.98

Penalises downside volatility only.

Std Deviation (3Y)

11.4%

Lower = more consistent returns.

NAV Chart ₹23.20 24 Jun 2026

Simple Moving Avg: Click to draw · click again to remove

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth

Chart shows indexed performance (base = 100). Actual NAV: ₹23.20

Sector Shift Industry allocation month-over-month

Mar 2026 → Apr 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	53.0%	54.1%	▲ +1.2%
Healthcare Services	16.1%	16.7%	▲ +0.6%

Apr 2026 → May 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	54.1%	54.2%	● +0.1%
Healthcare Services	16.7%	16.5%	▼ -0.2%

↑

Biggest Add

Laurus Labs Limited

+0.51% · now 3.16%

↓

Biggest Trim

Sun Pharmaceutical Industries Limited

-0.48% · now 11.42%

What Changed in the Portfolio This Month?

Comparing Apr 2026 → May 2026

Apr 2026 → May 2026

↑ 11 Increased ↓ 12 Decreased

#	Stock	Sector	Apr 2026	May 2026	Change
1	Laurus Labs Limited ₹5.63 Cr	Pharmaceuticals & Biotechnology	2.65%	3.16%	+0.51%
2	Biocon Limited ₹3.05 Cr	Pharmaceuticals & Biotechnology	1.49%	1.71%	+0.22%
3	Gland Pharma Limited ₹1.97 Cr	Pharmaceuticals & Biotechnology	0.89%	1.10%	+0.21%
4	Zydus Lifesciences Limited ₹2.56 Cr	Pharmaceuticals & Biotechnology	1.23%	1.43%	+0.20%
5	Apollo Hospitals Enterprise Limited ₹10.39 Cr	Healthcare Services	5.65%	5.83%	+0.18%
6	Cipla Limited ₹9.33 Cr	Pharmaceuticals & Biotechnology	5.08%	5.24%	+0.16%
7	Torrent Pharmaceuticals Limited ₹6.16 Cr	Pharmaceuticals & Biotechnology	3.40%	3.46%	+0.06%
8	Mankind Pharma Limited ₹3.47 Cr	Pharmaceuticals & Biotechnology	1.91%	1.95%	+0.04%
9	JB Chemicals & Pharmaceuticals Limited ₹2.20 Cr	Pharmaceuticals & Biotechnology	1.21%	1.24%	+0.03%
10	Narayana Hrudayalaya Limited ₹1.59 Cr	Healthcare Services	0.86%	0.89%	+0.03%
11	Global Health Limited ₹1.13 Cr	Healthcare Services	0.62%	0.63%	+0.01%

#	Stock	Sector	Apr 2026	May 2026	Change
1	Sun Pharmaceutical Industries Limited ₹20.34 Cr	Pharmaceuticals & Biotechnology	11.90%	11.42%	-0.48%
2	Max Healthcare Institute Limited ₹8.85 Cr	Healthcare Services	5.30%	4.97%	-0.33%
3	Dr. Reddy's Laboratories Limited ₹8.33 Cr	Pharmaceuticals & Biotechnology	4.92%	4.68%	-0.24%
4	Glenmark Pharmaceuticals Limited ₹4.16 Cr	Pharmaceuticals & Biotechnology	2.56%	2.34%	-0.22%
5	Lupin Limited ₹6.71 Cr	Pharmaceuticals & Biotechnology	3.97%	3.77%	-0.20%
6	Fortis Healthcare Limited ₹5.37 Cr	Healthcare Services	3.11%	3.01%	-0.10%
7	Divi's Laboratories Limited ₹9.38 Cr	Pharmaceuticals & Biotechnology	5.33%	5.27%	-0.06%
8	GlaxoSmithKline Pharmaceuticals Limited ₹1.10 Cr	Pharmaceuticals & Biotechnology	0.68%	0.62%	-0.06%
9	IPCA Laboratories Limited ₹2.51 Cr	Pharmaceuticals & Biotechnology	1.46%	1.41%	-0.05%
10	Alkem Laboratories Limited ₹3.10 Cr	Pharmaceuticals & Biotechnology	1.77%	1.74%	-0.03%
11	Aurobindo Pharma Limited ₹4.39 Cr	Pharmaceuticals & Biotechnology	2.49%	2.47%	-0.02%
12	Emcure Pharmaceuticals Limited ₹56.82 L	Pharmaceuticals & Biotechnology	0.33%	0.32%	-0.01%

What Stocks Does This Fund Hold?

25 stocks — May 2026

#	Stock	Sector	Weight & Value
1	Sun Pharmaceutical Industries Limited ₹20.34 Cr	Pharmaceuticals & Biotechnology	11.42%
2	Apollo Hospitals Enterprise Limited ₹10.39 Cr	Healthcare Services	5.83%
3	Divi's Laboratories Limited ₹9.38 Cr	Pharmaceuticals & Biotechnology	5.27%
4	Cipla Limited ₹9.33 Cr	Pharmaceuticals & Biotechnology	5.24%
5	Max Healthcare Institute Limited ₹8.85 Cr	Healthcare Services	4.97%
6	Dr. Reddy's Laboratories Limited ₹8.33 Cr	Pharmaceuticals & Biotechnology	4.68%
7	Lupin Limited ₹6.71 Cr	Pharmaceuticals & Biotechnology	3.77%
8	Torrent Pharmaceuticals Limited ₹6.16 Cr	Pharmaceuticals & Biotechnology	3.46%
9	Laurus Labs Limited ₹5.63 Cr	Pharmaceuticals & Biotechnology	3.16%
10	Fortis Healthcare Limited ₹5.37 Cr	Healthcare Services	3.01%
11	Aurobindo Pharma Limited ₹4.39 Cr	Pharmaceuticals & Biotechnology	2.47%
12	Glenmark Pharmaceuticals Limited ₹4.16 Cr	Pharmaceuticals & Biotechnology	2.34%
13	Mankind Pharma Limited ₹3.47 Cr	Pharmaceuticals & Biotechnology	1.95%
14	Alkem Laboratories Limited ₹3.10 Cr	Pharmaceuticals & Biotechnology	1.74%
15	Biocon Limited ₹3.05 Cr	Pharmaceuticals & Biotechnology	1.71%
16	Zydus Lifesciences Limited ₹2.56 Cr	Pharmaceuticals & Biotechnology	1.43%
17	IPCA Laboratories Limited ₹2.51 Cr	Pharmaceuticals & Biotechnology	1.41%
18	JB Chemicals & Pharmaceuticals Limited ₹2.20 Cr	Pharmaceuticals & Biotechnology	1.24%
19	Aster DM Healthcare Limited ₹2.00 Cr	Healthcare Services	1.12%
20	Gland Pharma Limited ₹1.97 Cr	Pharmaceuticals & Biotechnology	1.10%
21	Narayana Hrudayalaya Limited ₹1.59 Cr	Healthcare Services	0.89%
22	Ajanta Pharma Limited ₹1.51 Cr	Pharmaceuticals & Biotechnology	0.85%
23	Global Health Limited ₹1.13 Cr	Healthcare Services	0.63%
24	GlaxoSmithKline Pharmaceuticals Limited ₹1.10 Cr	Pharmaceuticals & Biotechnology	0.62%
25	Emcure Pharmaceuticals Limited ₹56.82 L	Pharmaceuticals & Biotechnology	0.32%